These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 4181505)

  • 1. [Notes on the more effective fibrinolytic effect of nicotinic acid in an extemporaneous drug association].
    Ferliga G
    G Gerontol; 1967 Jun; 15(6):737-42. PubMed ID: 5604105
    [No Abstract]   [Full Text] [Related]  

  • 2. [Proposals for an outline of fibrinolytic-clearing therapy in coronary diseases].
    Ferliga G
    G Gerontol; 1967 Jul; 15(7):813-26. PubMed ID: 5606218
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combined fibrinolytic-clearing treatment in obliterative endareteritis in the aged patient].
    Baldoni E
    G Gerontol; 1967 Dec; 15(12):1477-89. PubMed ID: 5618944
    [No Abstract]   [Full Text] [Related]  

  • 4. On the effectiveness of a combined clarifying-fibrinolytic therapy in the preventive and curative treatment of arteriosclerosis and its sequelae.
    Ferliga G
    G Gerontol; 1966 Jun; 14(6):555-69. PubMed ID: 5989598
    [No Abstract]   [Full Text] [Related]  

  • 5. [Favorable effect of nicotinic acid on lipoprotein normalization with temporary drug association].
    Ferliga G
    G Gerontol; 1967 Nov; 15(11):1381-7. PubMed ID: 5617990
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antisclerotic therapy in ophthalmology].
    Margolis MG
    Vestn Oftalmol; 1973; 6():84-7. PubMed ID: 4133133
    [No Abstract]   [Full Text] [Related]  

  • 7. [The present status of treatment of arteriosclerosis].
    Apostoloff E
    Dtsch Gesundheitsw; 1967 Feb; 22(8):337-47. PubMed ID: 4869957
    [No Abstract]   [Full Text] [Related]  

  • 8. [DRUGS LOWERING THE CHOLESTEROL LEVEL IN THE BLOOD].
    MARKIEWICZ M
    Pol Tyg Lek; 1963 Sep; 18():1412-6. PubMed ID: 14087059
    [No Abstract]   [Full Text] [Related]  

  • 9. Possibilities of development of fibrinolytic activity with new and projected agents.
    Cliffton EE
    Angiologica; 1968; 5(2):146-60. PubMed ID: 4232515
    [No Abstract]   [Full Text] [Related]  

  • 10. Modification of atherosclerosis by agents that do not lower cholesterol.
    Cleland JG; Krikler DM
    Br Heart J; 1993 Jan; 69(1 Suppl):S54-62. PubMed ID: 8427766
    [No Abstract]   [Full Text] [Related]  

  • 11. [Proposals for a plan of fibrinolytic-clearing therapy of peripheral obstructive arteriopathy].
    Ferliga G
    G Gerontol; 1967 Aug; 15(8):955-71. PubMed ID: 4181505
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.